Prevalence and clinical relevance of cyclooxygenase-1 and -2 expression in stage IIB cervical adenocarcinoma

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 148, Issue 1, 2010, Pages 62-66

  Jung, Yong Wook ^a   Kim, Sang Wun ^a   Kim, Sunghoon ^a   Kim, Jae Hoon ^a   Cho, Nam Hoon ^a   Kim, Jae Wook ^b   Kim, Young Tae ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Kwandong University College of Medicine   (South Korea)

Author keywords

Adenocarcinoma; Cervical cancer; Cyclooxygenase 1; Cyclooxygenase 2; Prognosis

Indexed keywords

CISPLATIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIPLE CYCLE TREATMENT; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA;

EID: 72049113571     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.09.011     Document Type: Article

References (21)

1. Manchana T., Triratanachat S., Sirisabya N., Vasuratna A., Termrungruanglert W., and Tresukosol D. Prevalence and prognostic significance of COX-2 expression in stage IB cervical cancer. Gynecol Oncol 100 3 (2006) 556-560
2. Chen Y.J., Wang L.S., Wang P.H., et al. High cyclooxygenase-2 expression in cervical adenocarcinomas. Gynecol Oncol 88 3 (2003) 379-385
3. Chen T.H., Fukuhara K., Mandai M., et al. Increased cyclooxygenase-2 expression is correlated with suppressed antitumor immunity in cervical adenocarcinomas. Int J Gynecol Cancer 16 2 (2006) 772-779
4. Baltazar F., Filho A.L., Pinheiro C., et al. Cyclooxygenase-2 and epidermal growth factor receptor expressions in different histological subtypes of cervical carcinomas. Int J Gynecol Pathol 26 3 (2007) 235-241
5. Lindström A.K., Stendahl U., Tot T., Lidström B.M., and Hellberg D. Predicting the outcome of squamous cell carcinoma of the uterine cervix using combinations of individual tumor marker expressions. Anticancer Res 27 3B (2007) 1609-1615
6. Kim J.S., Li S., Kim J.M., Yeo S.G., Kim K.H., and Cho M.J. Cyclooxygenase-2 expression as a predictor of para-aortic lymph node recurrence in uterine cervical cancer. Int J Radiat Oncol Biol Phys 70 5 (2008) 1516-1521
7. Kim H.J., Wu H.G., Park I.A., and Ha S.W. High cyclooxygenase-2 expression is related with distant metastasis in cervical cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys 55 1 (2003) 16-20
8. Kang S., Kim M.H., Park I.A., et al. Elevation of cyclooxygenase-2 is related to lymph node metastasis in adenocarcinoma of uterine cervix. Cancer Lett 237 2 (2006) 305-311
9. Gaffney D.K., Holden J., Davis M., Zempolich K., Murphy K.J., and Dodson M. Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy. Int J Radiat Oncol Biol Phys 49 5 (2001) 1213-1217
10. Watson A.J. Chemopreventive effects of NSAIDs against colorectal cancer: regulation of apoptosis and mitosis by COX-1 and COX-2. Histol Histopathol 13 2 (1998) 591-597
11. Sales K.J., Katz A.A., Howard B., Soeters R.P., Millar R.P., and Jabbour H.N. Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1. Cancer Res 62 2 (2002) 424-432
12. Narko K., Ristimäki A., MacPhee M., Smith E., Haudenschild C.C., and Hla T. Tumorigenic transformation of immortalized ECV endothelial cells by cyclooxygenase-1 overexpression. J Biol Chem 272 34 (1997) 21455-21460
13. Jeon Y.T., Song Y.C., Kim S.H., et al. Influences of cyclooxygenase-1 and -2 expression on the radiosensitivities of human cervical cancer cell lines. Cancer Lett 256 1 (2007) 33-38
14. Milas L., Kishi K., Hunter N., Mason K., Masferrer J.L., and Tofilon P.J. Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme. J Natl Cancer Inst 91 17 (1999) 1501-1504
15. Kim Y.B., Kim G.E., Pyo H.R., et al. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 60 3 (2004) 822-829
16. Landoni F., Maneo A., Colombo A., et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 350 9077 (1997) 535-540
17. Hopkins M.P., and Morley G.W. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 77 6 (1991) 912-917
18. Noriyuki M., Sumi T., Zhi X., et al. Vascular endothelial growth factor, matrix metalloproteinases, and cyclooxygenase-2 influence prognosis of uterine cervical cancer in young women. Int J Oncol 31 3 (2007) 531-536
19. Ferrandina G., Lauriola L., Distefano M.G., et al. Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients. J Clin Oncol 20 4 (2002) 973-981
20. Athavale R., Clooney K., O'Hagan J., Shawki H., Clark A.H., and Green J.A. COX-1 and COX-2 expression in stage I and II invasive cervical carcinoma: relationship to disease relapse and long-term survival. Int J Gynecol Cancer 16 3 (2006) 1303-1308
21. Gaffney D.K., Winter K., Dicker A.P., et al. Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128. Int J Radiat Oncol Biol Phys 69 1 (2007) 111-117